Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Keratosis, Actinic 3Carcinoma, Basal Cell 3Urinary Bladder Neoplasms 2Skin Neoplasms 2Lymphoma, Non-Hodgkin 2Carcinoma, Squamous Cell 2Stomatitis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Glioblastoma 1Depression 1Deglutition Disorders 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

Music Therapy 15Therapeutics 13Cognitive Behavioral Therapy 12Methods 9Surveys and Questionnaires 8Standard of Care 8Psychiatric Rehabilitation 8Educational Status 8Early Intervention, Educational 8Psilocybin 7Mindfulness 6Ketamine 6Hypnosis 6Control Groups 6Aromatherapy 6Acupuncture Therapy 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Counseling 5Art Therapy 5Saline Solution 4Imagery, Psychotherapy 4Esketamine 4Caregivers 4Behavior Therapy 4Autogenic Training 4Yoga 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anxiety Disorders × Niacinamide × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡